LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | NU7441 | 1.11 | uM | LJP5 | 3 | C09 | 72 | hr | 1657 | 5556 | 5505 | 1.0091 | 1.0131 |
BT-20 | Dactolisib | 1.11 | uM | LJP5 | 1 | M15 | 72 | hr | 1657 | 1968 | 5505 | 0.3575 | 0.0806 |
BT-20 | Dactolisib | 1.11 | uM | LJP5 | 2 | M15 | 72 | hr | 1657 | 1985 | 5505 | 0.3605 | 0.0850 |
BT-20 | Dactolisib | 1.11 | uM | LJP5 | 3 | M15 | 72 | hr | 1657 | 1928 | 5505 | 0.3502 | 0.0702 |
BT-20 | NVP-TAE684 | 1.11 | uM | LJP6 | 1 | K15 | 72 | hr | 1657 | 4437 | 5505 | 0.8059 | 0.7223 |
BT-20 | NVP-TAE684 | 1.11 | uM | LJP6 | 2 | K15 | 72 | hr | 1657 | 4072 | 5505 | 0.7396 | 0.6274 |
BT-20 | NVP-TAE684 | 1.11 | uM | LJP6 | 3 | K15 | 72 | hr | 1657 | 4317 | 5505 | 0.7841 | 0.6911 |
BT-20 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1657 | 2587 | 5505 | 0.4699 | 0.2415 |
BT-20 | Palbociclib | 1.11 | uM | LJP6 | 2 | E15 | 72 | hr | 1657 | 2424 | 5505 | 0.4403 | 0.1991 |
BT-20 | Palbociclib | 1.11 | uM | LJP6 | 3 | E15 | 72 | hr | 1657 | 2649 | 5505 | 0.4811 | 0.2576 |
BT-20 | PD0325901 | 1.11 | uM | LJP5 | 1 | C03 | 72 | hr | 1657 | 4542 | 5505 | 0.8250 | 0.7496 |
BT-20 | PD0325901 | 1.11 | uM | LJP5 | 2 | C03 | 72 | hr | 1657 | 4768 | 5505 | 0.8660 | 0.8083 |
BT-20 | PD0325901 | 1.11 | uM | LJP5 | 3 | C03 | 72 | hr | 1657 | 5051 | 5505 | 0.9174 | 0.8818 |
BT-20 | PD0325901 | 1.11 | uM | LJP6 | 1 | E03 | 72 | hr | 1657 | 3865 | 5505 | 0.7020 | 0.5736 |
BT-20 | PD0325901 | 1.11 | uM | LJP6 | 2 | E03 | 72 | hr | 1657 | 4641 | 5505 | 0.8430 | 0.7753 |
BT-20 | PD0325901 | 1.11 | uM | LJP6 | 3 | E03 | 72 | hr | 1657 | 4550 | 5505 | 0.8264 | 0.7516 |
BT-20 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1657 | 6304 | 5505 | 1.1450 | 1.2075 |
BT-20 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1657 | 6582 | 5505 | 1.1955 | 1.2797 |
BT-20 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1657 | 6243 | 5505 | 1.1339 | 1.1916 |
BT-20 | PD184352 | 1.11 | uM | LJP5 | 1 | L09 | 72 | hr | 1657 | 5492 | 5505 | 0.9975 | 0.9965 |
BT-20 | PD184352 | 1.11 | uM | LJP5 | 2 | L09 | 72 | hr | 1657 | 5706 | 5505 | 1.0364 | 1.0521 |
BT-20 | PD184352 | 1.11 | uM | LJP5 | 3 | L09 | 72 | hr | 1657 | 5340 | 5505 | 0.9699 | 0.9570 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1657 | 4328 | 5505 | 0.7861 | 0.6940 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1657 | 4522 | 5505 | 0.8213 | 0.7444 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1657 | 4257 | 5505 | 0.7732 | 0.6755 |